Aarti Pharmalabs Limited (APL) is one of the leading small molecules CDMO in India which offers Contract Development and Manufacturing Services (CDMS) for drug substance (NCE, RSM, Intermediates) projects. We offer these services to global innovator pharmaceuticals and biotech companies for their small molecules NCE drug development programmes from lab scale to pilot and manufacturing scales focusing on the clinical phases (Ph-I/II/III), launch and commercial phase projects.
Our value proposition is that we provide these CDMO services to meet our clients needs with dedicated scientific and project teams, rapid development, manufacturing and act as an extension to our client’s laboratories. We want to be the “preferred CDMO partner” for our clients and want to help our clients to bring their molecules to market faster and make them successful. Our company’s culture is that we truly recognise the trust our clients place in us with their development projects.
